The Brighton Collaboration Setting Standards in Vaccine Safety 
About us Structure Process Working Groups Definitions & Guidelines Communications News
Your location: Home » Working Groups » Working Groups » Ongoing Working Groups » Guillain-Barré Syndrome » Members  
Working Groups
Working Group Member Selection and Process
Reference Groups


Members


Name Department Affiliation Country
Avila-Aguero Maria L. Pediatric Infectious Diseases Division Hospital Nacional de Niños CRI
Baxter Roger Kaiser Permanente Vaccine Study Center NCK Kaiser Permanente USA
Bilynsky Roman Child Neurology Patterson Army Health Center USA
Black Steve Center for Global Health Cincinnati Childrens Hospital USA
Buettcher Michael Paediatrics Children´s Hospital Aarau CHE
Burwen Dale Vaccine Safety Branch, Division of Epidemiology CBER, FDA USA
Caubel Patrick Pharmacovigilance North America Sanofi Pasteur, Inc. USA
Cleerbout Jan Clinical safety and Pharmacovigilance GSK Biologicals BEL
Cornblath David Neurology Johns Hopkins University School of Medicine USA
Edwards Kathy Division of Infectious Diseases Vanderbilt University School of Medicine USA
Gilmet Gregory Global Medical Affairs Sanofi Pasteur Inc. USA
Hughes Richard Department of Clinical Neuroscience King's College London School of Medicine GBR
Khuri-Bulos Najwa Peds Inf Diseases Jordan University Hospital JOR
Killion Leslie Global Safety Surveillance and Epidemiology Wyeth Pharmaceuticals USA
Kohl Katrin Division of Global Migration and Quarantine CDC USA
Koller Doser Annette Pharmacovigilance Berna Biotech Ltd. CHE
Korinthenberg Rudolf Division of Paediatric Neurology and Muscular Diseases University Hospital Freiburg DEU
Kulkarni Prasad Medical Serum Institute of India IND
Lasky Tamar (Tammi) Department of Pharmacy Practice University of Rhode Island College of Pharmacy USA
Law Barbara Science Section, Immunization and Respiatory Infections Division Public Health Agency of Canada CAN
Maltezou Helena Office for Nosocomial Infections, Antimicrobial Resistance, and Strategic Use of Antibiotics Hellenic Center for Disease Control and Prevention GRC
Marchant Colin D ||empty-atom-value|| Boston Medical Center USA
McBean Marshall Division of Health Services Research and Policy University of Minnesota USA
Munro Ursula pharmacovigilance SANOFI PASTEUR MSD GmbH DEU
Nell Patricia Roche Pharmaceuticals & retired Air Force USA
Oleske James M. Division of Allergy, Immunology and Infectious Diseases University Hospital, New Jersey Medical School USA
Papa Thomas Clinical Development Sanofi Pasteur Inc. USA
Prevots Rebecca Office of Global Affairs, National Institue of Allergy and Infectious Diseases NIH USA
Sejvar James NCID, Division of Viral and Rickettsial Diseases CDC USA
Shurin Paul Pediatrics Albert Einstein College of Medicine USA
Sparks Robert Vanderbilt Vaccine research Program Vanderbilt University Medical Center USA
Stoltman Gillian A. Public Health Waterwood Consulting USA
Vermeer Patricia Centre for Infectious disease contril-CIb National Institute of Public Health and Environment-RIVM, Vaccine Safety Surveillance Netherlands Vaccination Programme NLD
Wiznitzer Max Pediatric Neurology University Hospitals of Cleveland/Rainbow Babies & Childrens Hospital USA
Zorn Juergen Pharmacovigilance Novartis Vaccines DEU


 
> back to top